Clinical trial
A Pilot Comparative Study of the Genomic Molecular and Clinical Profiles of Patients With Lung Cancer, COPD, or Asthma Treated With Symbicort Turbuhaler
NCT00569712 is registered in ClinicalTrials.gov with British Columbia Cancer Agency as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Comparative Study of the Genomic Molecular and Clinical Profiles of Patients With Lung Cancer, COPD, or Asthma Treated With Symbicort Turbuhaler
- Lead sponsor
- British Columbia Cancer Agency
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2007
- Completion date
- December 31, 2008
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer, precancerous condition